XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The following table presents the computation of earnings per share for the three and nine months ended September 30, 2023 and 2022:
For the three months ended September 30,For the nine months ended September 30,
(in millions, except share/per share amounts)2023202220232022
Net income (loss)$45 $450 $2,215 $(1,052)
Number of common shares:
Weighted average outstanding1,101,231,113 1,110,259,907 1,100,895,642 1,113,705,502 
Issued upon assumed exercise of outstanding stock options —  — 
Effect of issuance of non-vested restricted common stock932,868 796,253 839,031 — 
Effect of issuance of non-vested restricted units1,689,617 1,466,701 1,133,002 — 
Effect of issuance of non-vested performance units174,036 —  — 
Weighted average and dilutive outstanding1,104,027,634 1,112,522,861 1,102,867,675 1,113,705,502 
Earnings (loss) per common share
Basic$0.04 $0.41 $2.01 $(0.94)
Diluted$0.04 $0.40 $2.01 $(0.94)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table presents the common stock shares equivalent excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2023 and 2022, as they would have had an antidilutive effect:
For the three months ended September 30,For the nine months ended September 30,
2023202220232022
Unexercised stock options820,138 1,961,128 835,362 2,467,127 
Unvested restricted common stock — 54,989 810,025 
Restricted units224,726 790,182 652,089 1,503,049 
Performance units — 764,916 474,093 
Total1,044,864 2,751,310 2,307,356 5,254,294